Tag Archives: biotechnology

BIO Provides Supplemental Comments on PTO s.101 Guidelines

Posted on October 21, 2014 by Warren Woessner

BIO recently generated a letter to the PTO on the March 6th Guidelines on the patent-eligibility of subject matter in the life sciences, particularly “natural products.” BIO invited a group of in-house and private practitioners to comment on the Guidelines … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , | Leave a comment

“The Good Wife” Defends GMOs

Posted on October 7, 2014 by Warren Woessner

Last Sunday’s episode of “The Good Wife” featured a Christian mediation between a farmer (Robert Joy) sued by a Pioneer-like company, represented by the actor Richard Thomas, for saving GMO corn seed for replanting. The facts were a mash-up of … Continue reading →

Posted in Ag Biotechnology, Patent Eligible Subject Matter | Tagged , , , , , , , , , | Leave a comment

American Calcar v. Amer. Honda Motor Co. – Therasense Goes Out For a Test Drive

Posted on September 30, 2014 by Warren Woessner

On Friday, in American Calcar v. Amer. Honda Motor Co., App. No. 2013-1061 (Fed. Cir., September 26, 2014) a divided Fed. Cir. panel affirmed the district court’s ruling, following remand, that three patents on a multimedia system for vehicle information … Continue reading →

Posted in Inequitable Conduct/Rule 56 | Tagged , , , , , , , | 1 Comment

Fed. Cir.: Antitrust Issues Can Arise From Hatch-Waxman Litigation

Posted on August 7, 2014 by Warren Woessner

In Tyco Healthcare Group v. Mutual Pharm. Co., App. no. 13-1386 (Fed. Cir. August 6, 2014), a divided panel of the court reversed a district court’s summary judgment ruling dismissing antitrust charges brought by ANDA filer Mutual against patent-holder Tyco. (A … Continue reading →

Posted in Antitrust Issues | Tagged , , , , , , , , | Leave a comment